Skip to main content

Table 2 Surgical data and pathological factors of the conversion therapy group

From: Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study

Variable

n = 18

Operating procedure

 Total gastrectomy

9(50.0%)

 Distal gastrectomy

9(50.0%)

LN dissection

 D2

14(77.8%)

 D2+

4(22.2%)

Combined resection

 Spleen

3(16.7%)

 Ovary

7(38.9%)

 Pancreas

1(5.6%)

Operation time (min)

223(157–329)

Blood loss (ml)

150(50–800)

Postoperative complications

6(15.8%)

 pneumonia

3

 anastomotic leakage

1

 abdominal abscess

2

Residual tumor

 CCR-0

15(83.3%)

 CCR-1

3(16.7%)

yp T grade

 T1

3(16.7%)

 T2

5(27.8%)

 T3

2(11.1%)

 T4a

7(38.9%)

 T4b

1(5.6%)

yp N grade

 N0

5(27.8%)

 N1

6(33.3)

 N2

5(27.8%)

 N3

2(11.1%)

Histological response

 G1a

0

 G1b

6(33.3%)

 G2

11(61.1%)

 G3

1(5.6%)

  1. LN Lymph node, CCR completeness of cytoreduction